National Cancer Institute,
(For i-Cancer 2019)
Sherry X. Yang is Chief of National Clinical Target Validation Laboratory, Division of Cancer Treatment and Diagnosis at the National Cancer Institute (NCI), Bethesda, Maryland. Dr. Yang joined the NCI in 2001 after completion of her training from the Johns Hopkins Oncology Center. Her research interests include clinical target validation and biomarker science towards precision oncology. Dr. Yang’s laboratory focuses on the predictive and prognostic biomarkers of targeted cancer therapeutics and chemotherapy in breast cancer and lung cancer as well as other cancer types. She is recipient of several biomarkers-related awards and innovations, and an editor of Handbook of Therapeutic Biomarkers in Cancer, 2nd edition.
(For i-Cancer 2019)
David I Smith received his PhD in Biochemistry from the University of Wisconsin in Madison in 1978. His first academic position was at Wayne State University School of Medicine and in 1996 he moved to the Mayo Clinic as a Professor in the Department of Laboratory Medicine and Pathology. He is also the Chairman of the Technology Assessment Group for the Mayo Clinic Center for Individualized Medicine. His laboratory utilizes next-generation sequencing to study the different ways that human papillomavirus can cause cancer in different tissues. His group also studies the common fragile sites which are regions of profound instability found in all individuals.
Higher Scientific Officer
The Institute of Cancer Research
(iWomen Health 2019)
J C Hahne received his PhD in Biochemistry from the Albert-Ludwigs-University Freiburg i.Br. (Germany). During his PhD work, he was trained in virology, cell- and molecular-biology.During several Postdoc positions in Department of Molecular Pathology at the University of Bonn (Germany), Charite Berlin (Germany), and Department of Gynaecology and Obstetrics at the University of Wuerzburg (Germany), he received a broad training and knowledge in molecular pathology and cancer research. At the moment, he is working in the Department of Molecular Pathology at the ICR (London, UK). He has published more than 65 papers in reputed journals and has been serving as an Editorial Board Member of repute.
Copyright © IMedical . All rights reserved.